Abstract

The objective of this study is to analyze weight loss and risk reduction of cardiovascular diseases in patients undergoing endoscopic gastroplasty over a 12-month period. The research methodology adopted was a retrospective study with patients from the center participating in the research to treat obesity and with clinical indication for the procedure, from January 2021 to January 2022, meeting the inclusion criteria: minimum age: 18 years old, Minimum BMI of 30 kg/m2 (grade I obesity) and also patients who have already undergone bariatric surgery in the past and gained weight again (gain of at least 10% of the minimum weight achieved after bariatric surgery). The results obtained demonstrate that in month 1, the average weight was 114.1 kg, while in month 12 it was 82.3 kg, a reduction of approximately 27.86% (P < 0.001), observing a trend of progressive reduction from 1.5 kg to each month There was an average reduction of 28.11% in BMI over the 12 months (P<0.01). As for the average WHR index, it also demonstrated a reduction, which allows us to affirm an improvement in the cardiovascular risk of patients who participated in this study (P< 0.01). The percentage of non-obese patients increased significantly from 0% to 16.28%, while the percentage of patients with Grade 2 and Grade 3 obesity decreased from 44.83% to 6.98% and from 48.28% to 1.16 %, respectively. This suggests a significant change in the distribution of patients’ BMI throughout the study. It was concluded that endoscopic gastroplasty proved to be safe as it did not present complications or complications and was efficient for weight loss and the risk of cardiovascular diseases in patients over a period of 12 months.

Keywords

Obesity, endoscopy, weight loss, cardiovascular diseases, endoscopic suture